These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18275591)

  • 21. Magnetic resonance adenosine perfusion imaging in patients after coronary artery bypass graft surgery.
    Klein C; Nagel E; Gebker R; Kelle S; Schnackenburg B; Graf K; Dreysse S; Fleck E
    JACC Cardiovasc Imaging; 2009 Apr; 2(4):437-45. PubMed ID: 19580726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac magnetic resonance derived late microvascular obstruction assessment post ST-segment elevation myocardial infarction is the best predictor of left ventricular function: a comparison of angiographic and cardiac magnetic resonance derived measurements.
    Wong DT; Leung MC; Richardson JD; Puri R; Bertaso AG; Williams K; Meredith IT; Teo KS; Worthley MI; Worthley SG
    Int J Cardiovasc Imaging; 2012 Dec; 28(8):1971-81. PubMed ID: 22310980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of small caliber coronary arteries on the diagnostic accuracy of adenosine stress cardiac magnetic resonance imaging.
    Pilz G; Heer T; Graw M; Ali E; Klos M; Scheck R; Zeymer U; Höfling B
    Clin Res Cardiol; 2011 Mar; 100(3):201-8. PubMed ID: 20862587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Automated Pixel-Wise Quantitative Myocardial Perfusion Mapping by CMR to Detect Obstructive Coronary Artery Disease and Coronary Microvascular Dysfunction: Validation Against Invasive Coronary Physiology.
    Kotecha T; Martinez-Naharro A; Boldrini M; Knight D; Hawkins P; Kalra S; Patel D; Coghlan G; Moon J; Plein S; Lockie T; Rakhit R; Patel N; Xue H; Kellman P; Fontana M
    JACC Cardiovasc Imaging; 2019 Oct; 12(10):1958-1969. PubMed ID: 30772231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenosine Stress and Rest T1 Mapping Can Differentiate Between Ischemic, Infarcted, Remote, and Normal Myocardium Without the Need for Gadolinium Contrast Agents.
    Liu A; Wijesurendra RS; Francis JM; Robson MD; Neubauer S; Piechnik SK; Ferreira VM
    JACC Cardiovasc Imaging; 2016 Jan; 9(1):27-36. PubMed ID: 26684978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic performance of stress perfusion and delayed-enhancement MR imaging in patients with coronary artery disease.
    Cury RC; Cattani CA; Gabure LA; Racy DJ; de Gois JM; Siebert U; Lima SS; Brady TJ
    Radiology; 2006 Jul; 240(1):39-45. PubMed ID: 16793971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenosine stress CMR T1-mapping detects early microvascular dysfunction in patients with type 2 diabetes mellitus without obstructive coronary artery disease.
    Levelt E; Piechnik SK; Liu A; Wijesurendra RS; Mahmod M; Ariga R; Francis JM; Greiser A; Clarke K; Neubauer S; Ferreira VM; Karamitsos TD
    J Cardiovasc Magn Reson; 2017 Oct; 19(1):81. PubMed ID: 29070069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is contrast-enhanced cardiac magnetic resonance imaging at 3 T superior to 1.5 T for detection of coronary artery disease?
    Walcher T; Ikuye K; Rottbauer W; Wöhrle J; Bernhardt P
    Int J Cardiovasc Imaging; 2013 Feb; 29(2):355-61. PubMed ID: 22825256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined coronary and perfusion cardiovascular magnetic resonance for the assessment of coronary artery stenosis.
    Bunce NH; Reyes E; Keegan J; Bunce C; Davies SW; Lorenz CH; Pennell DJ
    J Cardiovasc Magn Reson; 2004; 6(2):527-39. PubMed ID: 15137337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of combined magnetic resonance myocardial perfusion imaging and late gadolinium enhancement.
    Krittayaphong R; Chaithiraphan V; Maneesai A; Udompanturak S
    Int J Cardiovasc Imaging; 2011 Jun; 27(5):705-14. PubMed ID: 21479846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between regional myocardial oxygenation and perfusion in patients with coronary artery disease: insights from cardiovascular magnetic resonance and positron emission tomography.
    Karamitsos TD; Leccisotti L; Arnold JR; Recio-Mayoral A; Bhamra-Ariza P; Howells RK; Searle N; Robson MD; Rimoldi OE; Camici PG; Neubauer S; Selvanayagam JB
    Circ Cardiovasc Imaging; 2010 Jan; 3(1):32-40. PubMed ID: 19920032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intermediate-term prognostic value of reversible perfusion deficit diagnosed by adenosine CMR: a prospective follow-up study in a consecutive patient population.
    Buckert D; Dewes P; Walcher T; Rottbauer W; Bernhardt P
    JACC Cardiovasc Imaging; 2013 Jan; 6(1):56-63. PubMed ID: 23328562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A quantitative pixel-wise measurement of myocardial blood flow by contrast-enhanced first-pass CMR perfusion imaging: microsphere validation in dogs and feasibility study in humans.
    Hsu LY; Groves DW; Aletras AH; Kellman P; Arai AE
    JACC Cardiovasc Imaging; 2012 Feb; 5(2):154-66. PubMed ID: 22340821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicenter evaluation of dynamic three-dimensional magnetic resonance myocardial perfusion imaging for the detection of coronary artery disease defined by fractional flow reserve.
    Manka R; Wissmann L; Gebker R; Jogiya R; Motwani M; Frick M; Reinartz S; Schnackenburg B; Niemann M; Gotschy A; Kuhl C; Nagel E; Fleck E; Marx N; Luescher TF; Plein S; Kozerke S
    Circ Cardiovasc Imaging; 2015 May; 8(5):. PubMed ID: 25901043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value of vasodilator stress myocardial contrast echocardiography and magnetic resonance imaging for the differential diagnosis of ischemic versus nonischemic cardiomyopathy.
    Mor-Avi V; Koch R; Holper EM; Goonewardena S; Coon PD; Min JK; Fedson S; Ward RP; Lang RM
    J Am Soc Echocardiogr; 2008 May; 21(5):425-32. PubMed ID: 18187290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Added value of rest to stress study for recognition of artifacts in perfusion cardiovascular magnetic resonance.
    Thomson LE; Fieno DS; Abidov A; Slomka PJ; Hachamovitch R; Saouaf R; Friedman JD; Berman DS
    J Cardiovasc Magn Reson; 2007; 9(5):733-40. PubMed ID: 17891609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal imaging strategies to assess coronary blood flow and risk for patients with coronary artery disease.
    Jerosch-Herold M; Kwong RY
    Curr Opin Cardiol; 2008 Nov; 23(6):599-606. PubMed ID: 18830076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gadolinium-Free Cardiac MR Stress T1-Mapping to Distinguish Epicardial From Microvascular Coronary Disease.
    Liu A; Wijesurendra RS; Liu JM; Greiser A; Jerosch-Herold M; Forfar JC; Channon KM; Piechnik SK; Neubauer S; Kharbanda RK; Ferreira VM
    J Am Coll Cardiol; 2018 Mar; 71(9):957-968. PubMed ID: 29495995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Combined evaluation of myocardial perfusion and contractility by cardiac magnetic resonance with adenosine stress test: feasibility and accuracy in detecting coronary artery disease].
    Dellegrottaglie S; Cospite V; Pedrotti P; Pedretti S; Lanzarin B; Mauri F; Roghi A
    G Ital Cardiol (Rome); 2009 Feb; 10(2):101-7. PubMed ID: 19348147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of sulfur hexafluoride microbubble (SonoVue)-enhanced myocardial contrast echocardiography with gated single-photon emission computed tomography for detection of significant coronary artery disease: a large European multicenter study.
    Senior R; Moreo A; Gaibazzi N; Agati L; Tiemann K; Shivalkar B; von Bardeleben S; Galiuto L; Lardoux H; Trocino G; Carrió I; Le Guludec D; Sambuceti G; Becher H; Colonna P; Ten Cate F; Bramucci E; Cohen A; Bezante G; Aggeli C; Kasprzak JD
    J Am Coll Cardiol; 2013 Oct; 62(15):1353-61. PubMed ID: 23770168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.